Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Though, tabalumab's Phase II clinical studies showed success and proved effective, a recent report has revealed that Eli Lilly and Company's human monoclonal antibody failed in terms of meeting efficacy objectives in a next-stage trial.

Of total three Phase 3 rheumatoid arthritis registration studies, one study of the anti-BAFF monoclonal antibody failed, which the researchers say, was totally unexpected. However, the failure is in no way related to safety concerns.

Therefore, as per the findings, patients currently involved in other studies of tabalumab RA would continue the treatment. Lilly would also be working towards the development of additional treatment options so that patients with autoimmune diseases could have an option.

It has been told that the company would evaluate the candidate in two other studies related to Phase 3 RA registration following the open-label extension study as well as other smaller studies. Since, the company is of the belief that it does not have sufficient data to gain U. S. marketing clearance.

"We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development programme", sources quoted vice president for Lilly autoimmune product development Eiry Roberts as saying.


FrenchTribune Specials

Report: Microsoft acquiring SwiftKey for $250M

In a Tuesday report, the Financial Times (FT) has revealed that software biggie Microsoft has efforts underway to acquire UK-based developer SwiftKey -- the company behind popular software keyboard powered by artificial intelligence (AI).

Disclosing the financial terms of the acquisition, which has not yet been officially announced by...

Most Popular

Facebook shares increase 12% after company’s 2015 Q4 earnings report

Facebook shares witnessed an increase of nearly 12...

Scientists genetically engineer autistic monkeys in China

A team of scientists in China has genetically engineered...

Tim Cook: Apple Watch, Apple TV set new quarterly sales records in Q1 2016

Reporting tech giant Apple's financial results at an...

Poll

Can Greece Come out of Economic Problems: